Skip to content

MTA and Biodentine in Pulpotomized Primary Molars

Clinical and Radiographic Outcomes of MTA and Biodentine in Pulpotomized Primary Molars. A Randomized Clinical Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01591278
Enrollment
80
Registered
2012-05-03
Start date
2012-03-31
Completion date
2014-11-30
Last updated
2014-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Molar Pulpotomy

Brief summary

The objective of the study is to evaluate and compare, clinically and radiographically,the effects of MTA and Biodentine when used as pulp dressings following pulpotomy in human primary molars.

Interventions

OTHERPulpotomy

Comparison of two different pulp dressing agents

Sponsors

Cristina Cuadros
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
4 Years to 9 Years
Healthy volunteers
No

Inclusion criteria

* molars showing: 1. symptomless exposure of vital pulp by caries 2. no clinical or radiographic evidence of pulp degeneration (excessive bleeding from the root canal, internal root resorption, inter-radicular and/or furcal bone destruction) 3. the possibility of proper restoration of the teeth 4. no physiological resorption of more than one-third of the root

Exclusion criteria

* presence of systemic pathology and any history of allergic reaction to latex, local anaesthetics or to the constituents of the test pulp dressing agents

Design outcomes

Primary

MeasureTime frame
Number of molars with clinical success12 months
Number of molars with radiographic success6 and 12 months

Secondary

MeasureTime frame
Number of molars with no evidence of external resorption6 and 12 months
Number of molars with no evidence of furcation radiolucency6 and 12 months
Number of molars with no symptoms of pain6 and 12 months
Number of molars with no evidence of radicular radiolucency6 and 12 months
Number of molars without fistulation6 and 12 months
Number of molars without pathological mobility.6 and 12 months
Number of molars without swelling6 and 12 months
Number of molars with no evidence of internal resorption6 and 12 months

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026